Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2025-12-24 @ 5:03 PM
NCT ID:
NCT04684550
Eligibility Criteria:
Inclusion Criteria:
* Specialist physicians, resident physicians, medical students, and nursing personnel who work at the San Ignacio University Hospital.
* Subjects of any sex over 18 years of age who work as health care personnel, in care services that care for patients with a suspected or confirmed diagnosis of COVID-19 and who are active during the study recruitment.
* That they have not presented general symptoms such as malaise, fever, cough, dyspnea or muscle pain during the last 7 days.
* Subjects negative to the antigen test for COVID-19.
Exclusion Criteria:
* Subjects considered as a resolved case of COVID-19 infection, according to guidelines from the Colombian National Institute of Health.
* Health personnel with social distancing due to close contact without personal protective equipment with patients confirmed to be infected or taking any medication as a possible prophylaxis for COVID-19 (example: chloroquine, hydroxychloroquine, azithromycin)
* Health workers who have permits or temporary withdrawal from their hospital work for more than one week during the month of the study.
* Some type of allergy to chlorinated agents or hypersensitivity to HClO
* Known diagnosis of upper airway respiratory disease where COVID-19 such as the common cold, sinusitis, pharyngitis, laryngotracheitis and epiglottitis or lower such as bronchiolitis, pneumonia, and mixed conditions have been ruled out.
* Previous COVID19 infection determined by positive PCR or positive serum antibody titers.
* Any condition that in the principal investigator's discretion renders the subject ineligible to participate in the study.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04684550
Study Brief:
Protocol Section:
NCT04684550